Loading...
Impact of standard of care treatments and disease variables on outcomes in systemic lupus erythematosus trials: analysis from the Lupus Foundation of America Collective Data Analysis Initiative
OBJECTIVE: Most clinical trials for systemic lupus erythematosus (SLE) study the efficacy and safety of investigational agents added to variable background immunosuppressants, which has resulted in high response rates in patients treated with placebo plus standard of care (SOC) plus rescue measures....
Na minha lista:
| Udgivet i: | Eur J Rheumatol |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Medical Research and Education Association
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5042268/ https://ncbi.nlm.nih.gov/pubmed/27708963 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5152/eurjrheum.2015.0048 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|